Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors (original) (raw)

Oncogene volume 20, pages 7812–7816 (2001)Cite this article

Abstract

Tumor promoters are non-mutagenic chemicals which increase the probability of cancer by accelerating the clonal expansion of cells transformed during tumor initiation. Phenobarbital (PB) is an antiepileptic drug which promotes hepatocarcinogenesis in rodents when administered subsequent to an initiating carcinogen like diethylnitrosamine (DEN). Here we have investigated the prevalence and patterns of mutations in two genes, Ha-ras and β-catenin, both known mutational targets in mouse hepatocarcinogenesis. Liver tumors were generated by a single administration of DEN to 6 week old mice followed by feeding of PB (0.05%) containing or control diet for 39 weeks. Mutations at Ha-ras codon 61 were screened by allele-specific oligonucleotide hybridization; β-catenin mutations were detected by direct sequencing of PCR products spanning exon 2. In tumors from mice treated with DEN alone, the prevalence of Ha-ras mutations was ∼30% (6/20), while no β-catenin mutations (0/13) were detectable in tumors of this treatment group. By contrast, Ha-ras mutations were undetectable in tumors from mice treated with DEN/PB (0/32), while ∼80% (37/46) of tumors from this group showed β-catenin mutations. These results demonstrate that PB strongly affects the prevalence of mutations in the two cancer-related genes, presumably by positive and negative selection for cells harboring the respective mutation.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 50 print issues and online access

$259.00 per year

only $5.18 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

Download references

Acknowledgements

We thank Dr T Devereux for gift of β-catenin-mutated DNAs which were used as positive controls during the initial phases of the project. The excellent technical assistence of Mrs J Mahr and Mrs E Zabinsky is acknowledged. This study was supported in part by the Deutsche Forschungsgemeinschaft (SCHW 329/3-1).

Author information

Authors and Affiliations

  1. Institut für Toxikologie, Universität Tübingen, Wilhelmstr. 56, 72074 Tübingen, Germany
    Huriye Aydinlik, Tri Dung Nguyen, Oliver Moennikes, Albrecht Buchmann & Michael Schwarz

Authors

  1. Huriye Aydinlik
    You can also search for this author inPubMed Google Scholar
  2. Tri Dung Nguyen
    You can also search for this author inPubMed Google Scholar
  3. Oliver Moennikes
    You can also search for this author inPubMed Google Scholar
  4. Albrecht Buchmann
    You can also search for this author inPubMed Google Scholar
  5. Michael Schwarz
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toMichael Schwarz.

Rights and permissions

About this article

Cite this article

Aydinlik, H., Nguyen, T., Moennikes, O. et al. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors.Oncogene 20, 7812–7816 (2001). https://doi.org/10.1038/sj.onc.1204982

Download citation

Keywords

This article is cited by